TriSalus Life Sciences, Inc. (TLSI)
USD 3.76
(-1.31%)
USD 3.76
(-1.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 18.51 Million | 12.39 Million | 8.4 Million | 5.43 Million |
| Cost of Revenue | 2.6 Million | 2.25 Million | 1.19 Million | 2.19 Million |
| Gross Profit | 15.9 Million | 10.14 Million | 7.2 Million | 3.23 Million |
| Operating Expenses | 70.05 Million | 46.57 Million | 31.24 Million | 29.02 Million |
| Selling, General and Administrative Expenses | 40.54 Million | 25.22 Million | 17.01 Million | 13.05 Million |
| Research and Development Expenses | 29.51 Million | 21.35 Million | 14.22 Million | 15.82 Million |
| Other Expenses | - | -8.73 Million | 746 Thousand | - |
| Cost and Expenses | 72.66 Million | 48.83 Million | 32.43 Million | 31.22 Million |
| Operating Income | -54.15 Million | -36.43 Million | -24.03 Million | -25.64 Million |
| Interest Expense | 16 Thousand | 1000.00 | 1.76 Million | - |
| Income Tax Expense | 9000.00 | 9000.00 | 3000.00 | 4000.00 |
| Earnings before Tax | -59.02 Million | -47.17 Million | -28.84 Million | -31.82 Million |
| Net Income | -59.03 Million | -47.18 Million | -28.84 Million | -31.83 Million |
| Earnings Per Share Basic | -6.73 | -1.59 | -0.92 | -1.04 |
| Earnings Per Share Diluted | -6.73 | -1.59 | -0.92 | -1.04 |
| Weighted Average Shares Outstanding | 9.39 Million | 29.6 Million | 31.25 Million | 30.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.39 Million | 29.6 Million | 31.25 Million | 30.56 Million |
| Gross Margin | 0.86 | 0.82 | 0.86 | 0.60 |
| EBIT Margin | -3.15 | -3.60 | -2.72 | -4.66 |
| Profit Margin | -3.19 | -3.81 | -3.43 | -5.86 |
| EBITDA | -58.29 Million | -46.76 Million | -23.56 Million | -25.32 Million |
| Earnings Before Tax Margin | -2.93 | -2.94 | -2.86 | -4.72 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.36 Million | 6.45 Million | 5.72 Million | 18.51 Million | 5.19 Million | 4.61 Million |
| Cost of Revenue | 1.1 Million | 971 Thousand | 582 Thousand | 2.6 Million | 589 Thousand | 772 Thousand |
| Gross Profit | 6.25 Million | 5.48 Million | 5.13 Million | 15.9 Million | 4.6 Million | 3.84 Million |
| Operating Expenses | 14.43 Million | 17.17 Million | 19.25 Million | 70.05 Million | 23.08 Million | 15.27 Million |
| Selling, General and Administrative Expenses | 9.76 Million | 11.31 Million | 11.61 Million | - | 13.71 Million | 8.41 Million |
| Research and Development Expenses | 4.66 Million | 5.85 Million | 7.63 Million | - | 9.36 Million | 6.86 Million |
| Other Expenses | -44 Thousand | -153 Thousand | -323 Thousand | -379 Thousand | -13 Thousand | -25 Thousand |
| Cost and Expenses | 15.53 Million | 18.14 Million | 19.83 Million | 72.66 Million | 23.67 Million | 16.04 Million |
| Operating Income | -8.17 Million | -11.68 Million | -14.11 Million | -54.15 Million | -18.47 Million | -11.43 Million |
| Interest Expense | 877 Thousand | 3000.00 | 3000.00 | 16 Thousand | 4000.00 | 4000.00 |
| Income Tax Expense | 7000.00 | 3000.00 | 1000.00 | 9000.00 | -112 Thousand | 13 Thousand |
| Earnings before Tax | -4.32 Million | -13.21 Million | -35.5 Million | -59.02 Million | -1.28 Million | -13.96 Million |
| Net Income | -4.33 Million | -13.21 Million | -35.5 Million | -59.03 Million | -1.28 Million | -13.97 Million |
| Earnings Per Share Basic | -0.18 | -0.57 | -3.78 | - | -0.10 | -1.73 |
| Earnings Per Share Diluted | -0.18 | -0.57 | -3.78 | - | -0.10 | -1.73 |
| Weighted Average Shares Outstanding | 23.9 Million | 23.32 Million | 9.39 Million | 9.39 Million | 13.17 Million | 8.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.9 Million | 23.32 Million | 9.39 Million | 9.39 Million | 13.17 Million | 8.06 Million |
| Gross Margin | 0.85 | 0.85 | 0.90 | 0.86 | 0.89 | 0.83 |
| EBIT Margin | -1.07 | -1.79 | -2.45 | - | -3.54 | -2.48 |
| Profit Margin | -0.59 | -2.05 | -6.21 | -3.19 | -0.25 | -3.03 |
| EBITDA | -7.9 Million | -11.55 Million | -13.99 Million | - | -18.37 Million | -11.42 Million |
| Earnings Before Tax Margin | -1.11 | -1.81 | -2.47 | -2.93 | -3.56 | -2.48 |
GDEN
TRRGF
MHN
TRATF
1336
SES